Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study

BACKGROUND: Dialysis patients are at risk for lower SARS-CoV-2-vaccine immunogenicity than the normal population. We assessed immunogenicity to a first mRNA- or vector-based SARS-CoV-2-vaccination dose in dialysis patients. METHODS: In a multicenter observational pilot study, 2 weeks after a first v...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesny, Paul, Anderson, Mark, Cloherty, Gavin, Stec, Michael, Haase-Fielitz, Anja, Haarhaus, Mathias, Santos, Carla, Lucas, Carlos, Macario, Fernando, Haase, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164063/
https://www.ncbi.nlm.nih.gov/pubmed/34050904
http://dx.doi.org/10.1007/s40620-021-01076-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164063/
https://www.ncbi.nlm.nih.gov/pubmed/34050904
http://dx.doi.org/10.1007/s40620-021-01076-0

Ejemplares similares